SCHEMBL6979885

SCHEMBL6979885

C[C@](N)(C(=O)O)c1cccnc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
LMNA P02545 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP11B1 P15538 1/20 0.54
CYP11B2 P19099 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CYP2C19 P33261 1/20 0.47
CYP19A1 P11511 3/20 0.46
KCNA5 P22460 2/20 0.45
ALDH1A1 P00352 1/20 0.44
APP P05067 1/20 0.44
GAA P10253 1/20 0.44
HCAR3 P49019 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
SLC22A12 Q96S37 1/20 0.43
F7 P08709 1/20 0.43
F3 P13726 1/20 0.43
SARM1 Q6SZW1 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.43
SIRT6 Q8N6T7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979883 1.00 CYP1A2 (0.54) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL6037641 1.00 CYP1A2 (0.54) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL10772486 0.81 LMNA (0.57) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL4702232 0.81 LMNA (0.67) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL1690472 0.80 LMNA (0.56) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL30435487 0.80 CYP1A2 (0.56) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL1827065 0.80 CYP1A2 (0.56) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL28811862 0.79 CYP1A2 (0.54) CYP1A2LMNACYP3A4CYP11B1CYP11B2
SCHEMBL59841 0.78 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL220775 0.78 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0833839-B1 PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS ORTHO PHARMA CORP (US) 2003-01-08 EP disclosed
US-5827860-A Peptidyl heterocycles useful in the treatment of thrombin related disorders ORTHO PHARMACEUTICAL CORPORATION (US) 1998-10-27 US disclosed
US-5827866-A ANTICOAGULANTS ORTHO PHARMACEUTICAL CORPORATION (US) 1998-10-27 US disclosed
EP-0833839-A1 PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1998-04-08 EP disclosed
WO-1996040742-A1 PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATEDDISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-12-19 WO disclosed
WO-1996040741-A1 PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-12-19 WO disclosed
WO-1996040748-A1 PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-12-19 WO disclosed
US-5523308-A SERINE PROTEASES INHIBITORS; ORAL ANTICOAGULANTS; CHEMICAL INTERMEDIATES; DIPEPTIDES ORTHO PHARMACEUTICAL CORPORATION 1996-06-04 US disclosed